N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of IκBα kinase and nuclear factor-κB-regulated gene products

50Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

N-(4-hydroxyphenyl) retinamide [4-HPR], a synthetic retinoid, has been shown to inhibit tumor cell growth, invasion, and metastasis by a mechanism that is not fully understood. Because the nuclear factor-κB (NF-κB) lias also been shown to regulate proliferation, invasion, and metastasis of tumor cells, we postulated that 4-HPR modulates the activity of NF-κB. To test this postulate, we examined the effect of this retinoid on NF-κB and NF-κB-regulated gene products. We found that 4-HPR potentiated the apoptosis induced by tumor necrosis factor (TNF) and chemotherapeutic agents, suppressed TNF-induced invasion, and inhibited RANKL-induced osteoclastogenesis, all of which are tmown to require NF-κB activation. We found that 4-HPR suppressed both inducible and constitutive NF-κB activation without interfering with the direct DNA binding of NF-κB. 4-HPR was found to be synergistic with Velcade, a proteasome inhibitor. Further studies showed that 4-HPR blocked the phosphorylation and degradation of IκBα through the inhibition of activation of IκBα kinase (IKK), and this led to suppression of the phosphorylation and nuclear translocation of p65. 4-HPR also inhibited TNF-induced Akt activation linked with IKK activation. NF-κB-dependent reporter gene expression was also suppressed by 4-HPR, as was NF-κB reporter activity induced by TNFR1, TKADD, TRAF2, NIK, and IKK but not that induced by p65 transfection. The expression of NF-κB- regulated gene products involved in antiapoptosis (IAP1, Bfl-1/A1, Bcl-2, cFLIP, and TRAF1), proliferation (cyclin B1 and c-Myc), and angiogenesis (vascular endothelial growth factor, cyclooxygenase-2, and matrix metaloproteinase-9) were also down-regulated by 4-HPR. This correlated with potentiation of apoptosis induced by TNF and chemotherapeutic agents. ©2005 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Shishodia, S., Gutierrez, A. M., Lotan, R., & Aggarwal, B. B. (2005). N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of IκBα kinase and nuclear factor-κB-regulated gene products. Cancer Research, 65(20), 9555–9565. https://doi.org/10.1158/0008-5472.CAN-05-1585

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free